Rebecca Stauffer, PDA | Jan 30, 2017
The U.S. FDA announced in January it is extending the commenting period for the revised guidance document, Submission of Quality Metrics Data. Originally, the commenting period was slated to close Jan. 24; now it closes March 27.
PDA was one of several organizations urging FDA to extend the deadline for comments. Currently, a PDA commenting task force is drafting a set of official PDA comments on the revised guidance.
To offer your input on the guidance, consider attending the 2017 PDA Pharmaceutical Metrics and Quality Culture Conference, Feb. 21–22, in Bethesda, Md. Those planning to attend can also submit questions for discussion via the website for the meeting.